Expanding Microbiome Therapeutics Strategies to Unlock European Market Opportunities & Overcoming Regulatory Hurdles

• Understanding critical US and EU market regulatory differences, including SoHO, to streamline market entry and avoid delays
• Navigating complexities of establishing European trial sites and novel regulatory pathways to de-risk therapeutic development investment effectively
• Outlining key strategies for successfully introducing an approved US drug into the European market to ensure effective penetration

Speakers:

Jason Goldsmith

Senior Director, Microbiome Sciences

Nestle Health Science